Latest news

Thumbnail image for UK cancer patients waiting months for accurate diagnosis

UK cancer patients waiting months for accurate diagnosis

Cancer patients in the UK have reported that they continue to face difficulties in receiving a timely diagnosis, according to a survey commissioned by the All.Can initiative, presented at the Britain Against Cancer conference in London.

4th December 2018

Thumbnail image for NICE u-turn on Opdivo for skin cancer recurrence

NICE u-turn on Opdivo for skin cancer recurrence

NHS use of Bristol-Myers Squibb’s Opdivo to cut the risk of early stage skin cancer recurrence after surgery has now been approved by the National Institute for Health and Care Excellence

30th November 2018

Thumbnail image for EU approves Gilenya for paediatric MS

EU approves Gilenya for paediatric MS

European regulators have approved Novartis’ Gilenya for the treatment of children and adolescents from 10 to 17 years old with relapsing-remitting forms of multiple sclerosis (RRMS).

29th November 2018

Thumbnail image for Kalydeco approved by EU for CF in 12-24 month olds

Kalydeco approved by EU for CF in 12-24 month olds

Vertex Pharmaceuticals says the European Commission has granted approval of the label extension for Kalydeco, to include the treatment of patients with cystic fibrosis (CF) aged 12 to 24 months.

29th November 2018

Previous  --   1 2 3 4 5 6 7 8 9 10   --  Next

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download